Bennett D
Rush Alzheimer's Disease Center, Rush Presbyterian-St. Luke's Medical Center, Chicago, USA.
Int J Clin Pract Suppl. 2001 May(120):41-8.
Vascular dementia (VaD) refers to a heterogeneous group of conditions that include all dementia syndromes resulting from ischaemic, haemorrhagic, anoxic or hypoxic brain damage. VaD is the second most common cause of dementia in the elderly after Alzheimer's disease. Persons with VaD are at greater risk of morbidity and mortality compared with those without dementia or those with Alzheimer's disease, and appear to be at greater risk of institutionalisation. Despite the importance of the problem posed by VaD, few placebo-controlled, double-blind, randomised clinical trials have been conducted. Although dementia may result solely from the accumulation of brain damage from cerebrovascular disease (CVD), recent data suggest that VaD often results from a combination of both CVD and Alzheimer's disease ('mixed' dementia). This raises the possibility that persons with VaD may respond to medications that are commonly used to treat Alzheimer's disease.
血管性痴呆(VaD)指的是一组异质性疾病,包括由缺血性、出血性、缺氧性或低氧性脑损伤导致的所有痴呆综合征。VaD是老年人中仅次于阿尔茨海默病的第二大常见痴呆病因。与无痴呆症者或患阿尔茨海默病者相比,VaD患者发生发病和死亡的风险更高,而且似乎被送入机构照料的风险也更高。尽管VaD所带来的问题很重要,但很少有进行安慰剂对照、双盲、随机临床试验。虽然痴呆可能仅由脑血管疾病(CVD)导致的脑损伤累积引起,但最近的数据表明,VaD通常是由CVD和阿尔茨海默病两者共同作用所致(“混合性”痴呆)。这增加了VaD患者可能对常用于治疗阿尔茨海默病的药物产生反应的可能性。